\-\ Texto\\:\\ \ \(0\)\
\-\ the\\ patient\\'s\\ right\\ breast\\ was\\ notably\\ larger\\ than\\ the\\ left\\,\\ with\\ a\\ markedly\\ palpable\\ mass\\ at\\ 12\\ o\\'clock\\.\\ \\ the\\ breast\\ was\\ warm\\ and\\ the\\ upper\\ half\\ of\\ the\\ breast\\ was\\ erythematous\\.\\ \\ the\\ patient\\ had\\ been\\ on\\ antibiotics\\ for\\ approximately\\ 5\\ days\\ at\\ the\\ time\\ of\\ the\\ mammogram\\.\ \(0\)\
\-\ the\\ patient\\ is\\ now\\ being\\ evaluated\\ for\\ treatment\\.\\ \\ a\\ pet\\ scan\\ confirmed\\ the\\ findings\\ of\\ the\\ ct\\ exam\\,\\ showing\\ a\\ large\\ right\\ breast\\ mass\\ with\\ regional\\ lymph\\ nodes\\ with\\ hypermetabolic\\ activity\\.\\ \\ there\\ was\\ no\\ evidence\\ of\\ another\\ primary\\ source\\.\ \(0\)\
\-\ the\\ mammogram\\ \\(mlo\\ view\\ provided\\,\\ as\\ the\\ copy\\ of\\ the\\ cc\\ view\\ was\\ of\\ poor\\ quality\\)\\ demonstrates\\ a\\ large\\ \\(3cm\\)\\ round\\ mass\\ with\\ well\\ circumscribed\\ margins\\.\\ \\ multiple\\ small\\ pleomorphic\\ calcifications\\ were\\ seen\\ within\\ the\\ mass\\.\\ \\ the\\ ct\\ exam\\ shows\\ the\\ corresponding\\ mass\\ in\\ the\\ right\\ breast\\,\\ as\\ well\\ as\\ a\\ large\\ abnormal\\ right\\ axillary\\ lymph\\ node\\.\\ \\ there\\ were\\ other\\ nodes\\ noted\\ in\\ the\\ supraclavicular\\ area\\ \\(not\\ shown\\)\\.\\ \\ there\\ were\\ no\\ lung\\ masses\\.\ \(0\)\
\-\ primary\\ small\\ cell\\ neuroendocrine\\ carcinoma\\ of\\ the\\ breast\ \(1\)\
\-\ abscess\ \(594\)\
\-\ infiltrating\\ ductal\\ carcinoma\ \(11\)\
\-\ metastatic\\ disease\ \(243\)\
\-\ primary\\ small\\ cell\\ neuroendocrine\\ carcinoma\\?\\?\ \(0\)\
\-\ 36\\ year\\ old\\ female\\ with\\ new\\ palpable\\ right\\ breast\\ mass\\.\\ \\ the\\ patient\\'s\\ breast\\ was\\ swollen\\,\\ erythematous\\ and\\ warm\\.\\ \\ she\\ was\\ treated\\ with\\ initial\\ clinical\\ success\\ with\\ antibiotics\\,\\ but\\ the\\ symptoms\\ returned\\.\\ \\ the\\ patient\\ underwent\\ an\\ ultrasound\\ exam\\ \\(not\\ provided\\)\\ and\\ mammography\\.\ \(0\)\
\-\ as\\ stated\\ in\\ the\\ factoid\\,\\ primary\\ small\\ cell\\ neuroendocrine\\ carcinoma\\ of\\ the\\ breast\\ is\\ extremely\\ rare\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ breast\\:\\ 0\\.4435064598375831\ \(0\)\
\-\ the\\:\\ 0\\.33851687681182613\ \(0\)\
\-\ neuroendocrine\\:\\ 0\\.2647317518929895\ \(0\)\
\-\ primary\\:\\ 0\\.16690811905862038\ \(0\)\
\-\ was\\:\\ 0\\.16555096023951807\ \(0\)\
\-\ carcinoma\\:\\ 0\\.16236489219071554\ \(0\)\
\-\ mass\\:\\ 0\\.15552592985996574\ \(0\)\
\-\ warm\\:\\ 0\\.1518365467820557\ \(0\)\
\-\ small\\:\\ 0\\.14001940541684435\ \(0\)\
\-\ erythematous\\:\\ 0\\.13776646698772443\ \(0\)\
\-\ mammogram\\:\\ 0\\.12957953563648364\ \(0\)\
\-\ cell\\:\\ 0\\.11645839673890701\ \(0\)\
\-\ nodes\\:\\ 0\\.11529529986820383\ \(0\)\
\-\ right\\:\\ 0\\.11249320332037836\ \(0\)\
\-\ provided\\:\\ 0\\.11134608718594516\ \(0\)\
\-\ patient\\:\\ 0\\.11035844820626703\ \(0\)\
\-\ as\\:\\ 0\\.10904825881520679\ \(0\)\
\-\ of\\:\\ 0\\.1062403600907672\ \(0\)\
\-\ lymph\\:\\ 0\\.1055383470991065\ \(0\)\
\-\ were\\:\\ 0\\.10494074048490884\ \(0\)\
\-\ exam\\:\\ 0\\.10248338025636418\ \(0\)\
\-\ large\\:\\ 0\\.10200478694490066\ \(0\)\
\-\ antibiotics\\:\\ 0\\.09998918853554925\ \(0\)\
\-\ view\\:\\ 0\\.09938898381944744\ \(0\)\
\-\ copy\\:\\ 0\\.09762363000674117\ \(0\)\
\-\ palpable\\:\\ 0\\.09534929553895319\ \(0\)\
\-\ with\\:\\ 0\\.09301585884553003\ \(0\)\
\-\ hypermetabolic\\:\\ 0\\.087208805242641\ \(0\)\
\-\ notably\\:\\ 0\\.08306524987602593\ \(0\)\
\-\ there\\:\\ 0\\.08100472473854654\ \(0\)\
\-\ quality\\:\\ 0\\.07896292950402657\ \(0\)\
\-\ regional\\:\\ 0\\.07554058185810796\ \(0\)\
\-\ mlo\\:\\ 0\\.07554058185810796\ \(0\)\
\-\ supraclavicular\\:\\ 0\\.07413940141133077\ \(0\)\
\-\ success\\:\\ 0\\.07349620239006849\ \(0\)\
\-\ 3cm\\:\\ 0\\.07096751110115328\ \(0\)\
\-\ mammography\\:\\ 0\\.07071705376541214\ \(0\)\
\-\ extremely\\:\\ 0\\.06953824024218408\ \(0\)\
\-\ pleomorphic\\:\\ 0\\.06867267429737269\ \(0\)\
\-\ stated\\:\\ 0\\.06711026391271632\ \(0\)\
\-\ axillary\\:\\ 0\\.06674974286731311\ \(0\)\
\-\ infiltrating\\:\\ 0\\.06657349839879707\ \(0\)\
\-\ cc\\:\\ 0\\.0657294363948316\ \(0\)\
\-\ well\\:\\ 0\\.06571700253803013\ \(0\)\
\-\ swollen\\:\\ 0\\.06556757969348263\ \(0\)\
\-\ source\\:\\ 0\\.06464012705228346\ \(0\)\
\-\ half\\:\\ 0\\.063918919331587\ \(0\)\
\-\ returned\\:\\ 0\\.06377977992046907\ \(0\)\
\-\ corresponding\\:\\ 0\\.06350629008181988\ \(0\)\
\-\ pet\\:\\ 0\\.06284886955971761\ \(0\)\
\-\ larger\\:\\ 0\\.06074405160078682\ \(0\)\
\-\ markedly\\:\\ 0\\.05991615003455133\ \(0\)\
\-\ ductal\\:\\ 0\\.05971787404414624\ \(0\)\
\-\ showing\\:\\ 0\\.05859297828720832\ \(0\)\
\-\ node\\:\\ 0\\.05832762266018264\ \(0\)\
\-\ evaluated\\:\\ 0\\.05798277868803772\ \(0\)\
\-\ margins\\:\\ 0\\.057898107269843055\ \(0\)\
\-\ poor\\:\\ 0\\.05724159399533214\ \(0\)\
\-\ 36\\:\\ 0\\.05617326135453327\ \(0\)\
\-\ round\\:\\ 0\\.05560327046606245\ \(0\)\
\-\ another\\:\\ 0\\.05553390418185464\ \(0\)\
\-\ not\\:\\ 0\\.05357960601581589\ \(0\)\
\-\ shown\\:\\ 0\\.05260583527599539\ \(0\)\
\-\ circumscribed\\:\\ 0\\.052551883782001076\ \(0\)\
\-\ ct\\:\\ 0\\.05167043609268784\ \(0\)\
\-\ at\\:\\ 0\\.05126371562333834\ \(0\)\
\-\ rare\\:\\ 0\\.05122871203465808\ \(0\)\
\-\ in\\:\\ 0\\.05064464376097352\ \(0\)\
\-\ confirmed\\:\\ 0\\.05003809078437042\ \(0\)\
\-\ activity\\:\\ 0\\.04982218133636912\ \(0\)\
\-\ calcifications\\:\\ 0\\.049526343752933764\ \(0\)\
\-\ factoid\\:\\ 0\\.04739223013751091\ \(0\)\
\-\ being\\:\\ 0\\.04728802844324021\ \(0\)\
\-\ new\\:\\ 0\\.046947137381593826\ \(0\)\
\-\ underwent\\:\\ 0\\.04674719512827742\ \(0\)\
\-\ now\\:\\ 0\\.046583105850392686\ \(0\)\
\-\ 12\\:\\ 0\\.04638914040070949\ \(0\)\
\-\ masses\\:\\ 0\\.04619828683078283\ \(0\)\
\-\ initial\\:\\ 0\\.04552357445589809\ \(0\)\
\-\ no\\:\\ 0\\.044135076170200675\ \(0\)\
\-\ area\\:\\ 0\\.04396116407124174\ \(0\)\
\-\ abscess\\:\\ 0\\.043575304818099944\ \(0\)\
\-\ approximately\\:\\ 0\\.043300089338072216\ \(0\)\
\-\ clinical\\:\\ 0\\.043006942249653506\ \(0\)\
\-\ days\\:\\ 0\\.04295877909060378\ \(0\)\
\-\ treated\\:\\ 0\\.042258795789517425\ \(0\)\
\-\ and\\:\\ 0\\.04206776875117611\ \(0\)\
\-\ ultrasound\\:\\ 0\\.04185775947622326\ \(0\)\
\-\ lung\\:\\ 0\\.04128046801431934\ \(0\)\
\-\ for\\:\\ 0\\.04113613450631663\ \(0\)\
\-\ abnormal\\:\\ 0\\.04076981949011241\ \(0\)\
\-\ she\\:\\ 0\\.04039587737699638\ \(0\)\
\-\ scan\\:\\ 0\\.040261019271679646\ \(0\)\
\-\ time\\:\\ 0\\.04022276752156531\ \(0\)\
\-\ shows\\:\\ 0\\.0398283794469069\ \(0\)\
\-\ been\\:\\ 0\\.039536431444685154\ \(0\)\
\-\ evidence\\:\\ 0\\.03851785349105408\ \(0\)\
\-\ than\\:\\ 0\\.03846831996757132\ \(0\)\
\-\ metastatic\\:\\ 0\\.037218217173184145\ \(0\)\
\-\ is\\:\\ 0\\.03716824535839071\ \(0\)\
\-\ symptoms\\:\\ 0\\.03712954880714979\ \(0\)\
\-\ upper\\:\\ 0\\.03626372456472488\ \(0\)\
\-\ noted\\:\\ 0\\.035979661079986555\ \(0\)\
\-\ other\\:\\ 0\\.03524116795576093\ \(0\)\
\-\ demonstrates\\:\\ 0\\.034092494153857546\ \(0\)\
\-\ had\\:\\ 0\\.03381071205450082\ \(0\)\
\-\ but\\:\\ 0\\.03355723833129915\ \(0\)\
\-\ findings\\:\\ 0\\.03349199346554767\ \(0\)\
\-\ multiple\\:\\ 0\\.033192161255242866\ \(0\)\
\-\ female\\:\\ 0\\.0327459334403739\ \(0\)\
\-\ treatment\\:\\ 0\\.032325667761092886\ \(0\)\
\-\ seen\\:\\ 0\\.031948283470881106\ \(0\)\
\-\ within\\:\\ 0\\.03125456087063429\ \(0\)\
\-\ disease\\:\\ 0\\.028485524790277366\ \(0\)\
\-\ an\\:\\ 0\\.025949716370407508\ \(0\)\
\-\ left\\:\\ 0\\.023148775945640826\ \(0\)\
\-\ year\\:\\ 0\\.02091334173534692\ \(0\)\
\-\ on\\:\\ 0\\.020495106067474414\ \(0\)\
\-\ old\\:\\ 0\\.020084047398830185\ \(0\)\
